A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity

Summary

The main purpose of this study is to evaluate how different dose levels of brenipatide work and how safe they are in healthy people with overweight or obesity. The study will assess the effects of different doses given as subcutaneous (under the skin) injections. Participation in this study will last about 42 weeks.

Timeline

Start

2026-03-18

Primary completion

2027-02

Completion

2027-02

Drugs

Indications